Index · Artikel · Novartis muscle wasting drug gets 'breakthrough' status

Novartis muscle wasting drug gets 'breakthrough' status

2013-08-20 7

résuméZURICH Novartis said on Tuesday U.S. regulators have granted breakthrough therapy status for its investigational compound bimagrumab for the potential treatment of patients with sporadic inclusion body myositis (sIBM). The U.S. Food and Drug Administ

ZURICH Novartis said on Tuesday U.S. regulators have granted breakthrough therapy status for its investigational compound bimagrumab for the potential treatment of patients with sporadic inclusion body myositis (sIBM).

The U.S. Food and Drug Administration (FDA) created the "breakthrough therapy" designation earlier this year for medicines deemed likely to demonstrate "substantial improvement" over existing drugs.

sIBM is a rare yet potentially life-threatening muscle-wasting condition. Patients suffering from the disease can gradually lose the ability to walk. There are currently no approved treatments, according to Novartis.

Bimagrumab was developed by Novartis in collaboration with Morphosys. The drug works by stimulating muscle growth by blocking from inhibitory molecules.

(This corrects day of the week to Tuesday from Thursday)

(Reporting by Caroline Copley)

NOVARTIS

Novartis muscle wasting drug gets 'breakthrough' status

ZURICH Novartis said on Tuesday U.S. regulators have granted breakthrough therapy status for its investigational compound bimagrumab for the potential treatment of patients with sporadic inclusion body myositis (sIBM). The U.S. Food and Drug Administ

2013-08-20 NOVARTIS
Novartis aims to show strength with muscle wasting drug

BASEL Fifteen years ago Ian Parkhill was diagnosed with a rare muscle-wasting disease that gradually robbed him of the strength in his thighs. Now, he struggles to walk. The waning muscle in his arms will soon hinder his ability to pull himself out o

2013-12-06 DRUG NOVARTIS MUSCLEWASTING
FDA delays decision on Sarepta's muscle-wasting disorder drug

n">The U.S. Food and Drug Administration deferred a highly anticipated decision on whether to approve Sarepta Therapeutics Inc's muscle-wasting disorder drug, a month after an advisory panel determined that the treatment was not effective. Sarepta

2016-05-25 FDA SAREPTA
Novartis bone marrow drug improves progression-free survival

ZURICH An experimental drug from Novartis significantly improved the length of time that patients lived with a type of bone marrow cancer without the disease worsening, according to a late-stage study presented on Monday. The Phase III trial in patie

2014-06-02 DRUG NOVARTIS
Sarepta says FDA asks for more data for its muscle-wasting treatment

n">Sarepta Therapeutics Inc said the U.S. Food and Drug Administration has requested for additional data for its muscle-wasting treatment as the agency decides whether to approve the drug or not. Shares of the company rose 24 percent to $19.90 in

2016-06-06 FDA SAREPTA
FDA seeks more data on Sarepta muscle disorder drug, shares slump

n">Sarepta Therapeutics Inc suffered yet another setback after U.S. regulators asked for more data on its experimental muscle disorder drug, a move that further delays the marketing application for the treatment. Nearly a third of Sarepta's market

2014-10-27 FDA SAREPTA
Novartis blood cancer drug wins U.S. OK after setback

n">The U.S. Food and Drug Administration on Monday approved Novartis AG's drug to treat patients who have relapsed after earlier therapies for multiple myeloma, an aggressive blood cancer, even though an advisory panel in November recommended agai

2015-02-23 FDA NOVARTIS
Novartis heart drug gets FDA's 'breakthrough' status

ZURICH Swiss pharmaceuticals company Novartis said on Friday U.S. regulators have given breakthrough therapy status to an investigational treatment for patients with acute heart failure, potentially fast tracking its development and approval. The U.S

2013-06-21 NOVARTIS
Novartis' meningitis B vaccine wins breakthrough therapy status in U.S.

ZURICH Novartis said U.S. health regulators have granted the Swiss drugmaker's meningitis B vaccine Bexsero breakthrough therapy status. The Basel-based company in a statement on Monday said it plans to file for U.S. approval of Bexsero as early as t

2014-04-07 USA NOVARTIS BEXSERO
AstraZeneca wins FDA breakthrough status for key cancer drug

LONDON The U.S. Food and Drug Administration has granted breakthrough therapy designation to AstraZeneca's biggest new drug hope ‍durvalumab as a treatment in bladder cancer, the drugmaker said on Wednesday. The experimental medicine is a so-called P

2016-02-17 CANCER Astrazeneca
Pfizer cancer drug wins special status; shares jump

n">U.S. regulators have granted a "breakthrough therapy" designation to an experimental Pfizer Inc treatment for breast cancer, lifting the company's shares and putting a spotlight on its growing cancer-drug portfolio. Analysts from JPMo

2013-04-10 PFIZER PALBOCICLIB
Ersatzhaut für Verbrennungsopfer Orphan-Drug-und biologischen Status von der FDA erteilt

Eine Gewebeersatztherapie eine Ersatzhaut zu schaffen katastrophalen Brandopfern eigenen Hautzellen 'wurde ein kombiniertes Orphan-Drug-und biologischen Produkt Status von der US Food and Drug Administration unter Verwendung der zur Behandlung von Pa

2012-06-13 New Jersey Philadelphia
FDA staff question Novartis cystic fibrosis drug

WASHINGTON U.S. drug reviewers questioned whether Novartis AG's experimental inhaled antibiotic powder truly helped cystic fibrosis patients breathe better, according to documents posted by the Food and Drug Administration on its website Friday. The

2012-08-31 FDA NOVARTIS
FDA panel backs Novartis cystic fibrosis drug

WASHINGTON Drug advisers on Wednesday backed a new form of Novartis AG's inhaled antibiotic that treats a lung infection linked to cystic fibrosis. A panel of outside advisers to the Food and Drug Administration voted 13 to 1 that Novartis had demons

2012-09-05 FDA NOVARTIS CYSTIC
US FDA probes brain infection in patient on Novartis's MS drug

n">The U.S. Food and Drug Administration said it was investigating a case of a rare and serious brain infection that developed in a patient in Europe, who was being treated with Novartis's multiple sclerosis drug, Gilenya. The FDA said this was th

2013-08-29 FDA NOVARTIS WARNING
FDA staff review recommends against Novartis heart failure drug

WASHINGTON A drug to treat acute heart failure made by Novartis AG should not be approved because there is insufficient evidence to show it improves symptoms, according to an initial review by the U.S. Food and Drug Administration. The review, posted

2014-03-25 FDA NOVARTIS DOCUMENTS
Novartis closes heart drug study early after strong results

ZURICH Novartis has ended a late-stage clinical trial of a chronic heart failure drug early, following strong interim results, giving the Swiss drugmaker a boost after recent setbacks to another heart failure medicine. The Basel-based firm said on Mo

2014-03-31 STUDY NOVARTIS HEARTDRUG
U.S. regulator rejects Novartis heart failure drug

ZURICH U.S. health regulators turned down an application to approve Novartis' experimental heart failure drug due to insufficient evidence that it improves symptoms, the Swiss drugmaker said on Friday. Novartis said in a statement the Food and Drug A

2014-05-16 NOVARTIS SERELAXIN
EU agency recommends against Novartis heart failure drug

ZURICH EU health regulators have recommended against approving Novartis's experimental heart failure drug for the second time this year due to insufficient evidence it improves symptoms, the Swiss drugmaker said in a statement on Friday. The ruling b

2014-05-23 NOVARTIS SERELAXIN
FDA sets approval path for Prosensa muscle disorder drug

n">Prosensa Holding NV said the U.S. Food and Drug Administration had outlined an accelerated regulatory approval path for its most advanced drug, aimed at treating a muscle disorder. The Netherlands-based company said on Tuesday it planned to con

2014-06-03 FDA PROSENSA

TOP

Day/
Week/
Original/
Recommand

Updated

Stethoskop Ersatz kann Bild der Lunge in Sekunden
Statt mit einem Arzt legte eine Kalt ass Stethoskop auf dem Rücken, Deep Breeze die Vibration Response Imaging System setzt 42 kalt ass Stethoskope auf dem Rücken. Durch die Verwendung von akustischen Schwingungen, die-Maschine angeschlossen an einen
Companies struggling to get H1N1 vaccine to U.S.
WASHINGTON The U.S. government may end up throwing away unused doses of swine flu vaccine if people cannot get it soon enough, the director of the U.S. Centers for Disease Control and Prevention said on Tuesday. Members of Congress questioned whether
Warum hat das alles passieren nach / während Kiffen?
was ist, wenn Sie Unkraut und spucken schwarz rauchen? und auch, was passiert, wenn Sie wirklich Hunger / Durst nach dem Rauchen Unkraut bekommen? und Ihre Augen fühlen sich schwer an, dass ihr gehen zu fallen outt bedeutet? und dann wie Sie Lust hab
Ich habe aus seit mehr als einem Monat NuvaRing. Ich möchte, dass meine Zeit in diesem Monat zu überspringen. Kann ich NuvaRing einfügen?
... Eine Woche vor, ich soll meine Zeit zu starten und verzögern es? ----schneiden---- In Antwort auf 2011-11-02 18.15 bis suzanne66 Sie könnten aber es gibt eine hohe Chance, dass Sie Durchbruch Blutungen aufgrund der hormonellen Ungleichgewicht erl
Montana Microburst Flacht Bäume wie Zahnstocher
Vor über hundert Jahren, am 30. Juni 1908 kam ein überirdisches Besucher auf unserem Planeten. Ein Felsbrocken (oder möglicherweise Eis) etwa 30 Meter über-die Größe eines Hauses Lauf in mit einer Geschwindigkeit wahrscheinlich 50 Mal von einer Geweh
Studie: Eltern Ziehe die Pille über Kondome für ihre Töchter im Teenageralter
Die Formen der Geburtenkontrolle , die Eltern am meisten "bequem" machen unterscheiden sich von denen , die am wirksamsten sind. M.Markus / Flickr "Wenn Ihr jugendlich Arzt fand heraus, Ihre Tochter, die Sex ist es akzeptabel oder inakzepta
Wie man Pilates-Kurse finden
Pilates-Kurse sind so beliebt, jetzt, dass es relativ einfach ist, sie zu finden. Ich sehe verfügbar Pilates-Kurse in die kleinsten Städte. Der Trick ist, herauszufinden, über sie. Auch in einer großen Stadt, könnte es ein wenig nehmen genau die rich
Frühe Mobilität nach Sprunggelenkfraktur: Ist es von Vorteil?
Wenn Sie Ihren Knöchel gebrochen haben, können Sie aus der physikalischen Therapie profitieren Sie wieder in Bewegung zu helfen, erhalten. Ihre Physiotherapeuten arbeiten mit Ihnen, den Knöchel und Beinbewegungsbereich (ROM), Kraft und Beweglichkeit
Kochen Methoden für die gesunde Ernährung
Ein Großteil der gesündesten Lebensstil aufrechtzuerhalten ist die Ernährung. Was ist Ihr Körper ingests ist der Treibstoff, es sich selbst zu heilen verwendet und führen Sie die Aufgaben, die Sie es brauchen, hoffentlich auch Übung. Aber es ist mehr
Ausbruch der Darmerkrankung Cyclosporiasis Sickens 200
Zysten des Parasiten Cyclospora cayetanensis enthält, aus einer Stuhlprobe entnommen. Credit: CDC Ein Ausbruch der Darmerkrankung cyclosporiasis hat in vier Staaten mehr als 200 Menschen krank gemacht, nach den Centers for Disease Control and Prevent